within Pharmacolibrary.Drugs.ATC.C;

model C09DA07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.8333333333333334,
    adminDuration  = 600,
    adminMass      = 0.08,
    adminCount     = 1,
    Vd             = 0.5,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 12.0
  );

  annotation(Documentation(
    info ="<html><body><p>Combination product containing telmisartan, an angiotensin II receptor antagonist, and hydrochlorothiazide, a thiazide diuretic, used for the management of hypertension in adults. Approved and in use today for lowering blood pressure and reducing cardiovascular risk.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical adult patient (no sex difference assumed) receiving oral telmisartan 80 mg and hydrochlorothiazide 25 mg, based on single-dose studies of each component and population PK literature for the combination, as no explicit published PK model for the combination exists.</p><h4>References</h4><ol><li>C L Young, V C Dias, J Stangier,Multiple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects.,Journal of clinical pharmacology,2000<a href='https://pubmed.ncbi.nlm.nih.gov/11185630/'>https://pubmed.ncbi.nlm.nih.gov/11185630/</a></li><li>Seol Ju Moon, Ji-Young Jeon, Kyung-Sang Yu, Min-Gul Kim,Pharmacokinetic Interaction Among Telmisartan, Amlodipine, and Hydrochlorothiazide After a Single Oral Administration in Healthy Male Subjects.,Clinical therapeutics,2019<a href='https://pubmed.ncbi.nlm.nih.gov/31564513/'>https://pubmed.ncbi.nlm.nih.gov/31564513/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C09DA07;
